BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32461218)

  • 1. Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.
    Mannu GS; Wang Z; Broggio J; Charman J; Cheung S; Kearins O; Dodwell D; Darby SC
    BMJ; 2020 May; 369():m1570. PubMed ID: 32461218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study.
    Mannu GS; Wang Z; Dodwell D; Broggio J; Charman J; Darby SC
    BMJ; 2024 Jan; 384():e075498. PubMed ID: 38267073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
    Thompson AM; Clements K; Cheung S; Pinder SE; Lawrence G; Sawyer E; Kearins O; Ball GR; Tomlinson I; Hanby A; Thomas JSJ; Maxwell AJ; Wallis MG; Dodwell DJ;
    Eur J Cancer; 2018 Sep; 101():210-219. PubMed ID: 30092498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
    Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
    JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.
    Schmitz RSJM; van den Belt-Dusebout AW; Clements K; Ren Y; Cresta C; Timbres J; Liu YH; Byng D; Lynch T; Menegaz BA; Collyar D; Hyslop T; Thomas S; Love JK; Schaapveld M; Bhattacharjee P; Ryser MD; Sawyer E; Hwang ES; Thompson A; Wesseling J; Lips EH; Schmidt MK;
    BMJ; 2023 Oct; 383():e076022. PubMed ID: 37903527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
    Virnig BA; Tuttle TM; Shamliyan T; Kane RL
    J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort.
    Sprague BL; Vacek PM; Herschorn SD; James TA; Geller BM; Trentham-Dietz A; Stein JL; Weaver DL
    Breast Cancer Res Treat; 2019 Feb; 174(1):227-235. PubMed ID: 30448897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second events following ductal carcinoma in situ of the breast: a register-based cohort study.
    Falk RS; Hofvind S; Skaane P; Haldorsen T
    Breast Cancer Res Treat; 2011 Oct; 129(3):929-38. PubMed ID: 21537936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
    Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
    Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery and adjuvant radiotherapy for unilateral ductal carcinoma in situ (DCIS) in women aged over 70 years: A population based cohort study.
    Jauhari Y; Gannon MR; Tsang C; Horgan K; Dodwell D; Clements K; Medina J; Tang S; Pettengell R; Cromwell DA
    Eur J Surg Oncol; 2019 Aug; 45(8):1378-1387. PubMed ID: 30878169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
    Wapnir IL; Dignam JJ; Fisher B; Mamounas EP; Anderson SJ; Julian TB; Land SR; Margolese RG; Swain SM; Costantino JP; Wolmark N
    J Natl Cancer Inst; 2011 Mar; 103(6):478-88. PubMed ID: 21398619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
    Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
    JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
    Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
    PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand.
    Cuncins-Hearn A; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G
    ANZ J Surg; 2007; 77(1-2):64-8. PubMed ID: 17295824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
    Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
    JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.